PAROLIN, MARIA CRISTINA
 Distribuzione geografica
Continente #
NA - Nord America 13.465
AS - Asia 2.216
EU - Europa 1.946
SA - Sud America 66
AF - Africa 39
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 6
Totale 17.751
Nazione #
US - Stati Uniti d'America 13.443
SG - Singapore 1.114
CN - Cina 846
IT - Italia 503
FI - Finlandia 384
DE - Germania 316
SE - Svezia 166
FR - Francia 140
UA - Ucraina 124
RU - Federazione Russa 106
GB - Regno Unito 98
VN - Vietnam 98
HK - Hong Kong 73
BR - Brasile 54
CI - Costa d'Avorio 32
IN - India 27
IE - Irlanda 24
NL - Olanda 24
CA - Canada 17
TR - Turchia 13
AT - Austria 12
BE - Belgio 11
AU - Australia 10
IR - Iran 10
JP - Giappone 10
PT - Portogallo 9
LT - Lituania 8
EU - Europa 6
KR - Corea 5
RO - Romania 4
CH - Svizzera 3
CO - Colombia 3
CZ - Repubblica Ceca 3
EC - Ecuador 3
ES - Italia 3
IQ - Iraq 3
MX - Messico 3
NZ - Nuova Zelanda 3
ZA - Sudafrica 3
AE - Emirati Arabi Uniti 2
AR - Argentina 2
AZ - Azerbaigian 2
BD - Bangladesh 2
CL - Cile 2
MY - Malesia 2
PL - Polonia 2
PY - Paraguay 2
RE - Reunion 2
SI - Slovenia 2
BG - Bulgaria 1
BZ - Belize 1
DZ - Algeria 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
KH - Cambogia 1
KW - Kuwait 1
KZ - Kazakistan 1
LK - Sri Lanka 1
MA - Marocco 1
NI - Nicaragua 1
NP - Nepal 1
RS - Serbia 1
SA - Arabia Saudita 1
TH - Thailandia 1
TW - Taiwan 1
Totale 17.751
Città #
Fairfield 1.751
Woodbridge 1.620
Houston 1.117
Chandler 1.115
Ann Arbor 1.017
Ashburn 790
Jacksonville 710
Wilmington 674
Seattle 585
Cambridge 569
Singapore 523
Boardman 349
Princeton 333
Santa Clara 303
Beijing 219
Roxbury 210
Des Moines 189
Helsinki 186
Medford 178
San Diego 173
Padova 142
Nanjing 141
Dong Ket 98
Hong Kong 68
Nanchang 47
Hebei 44
Shenyang 42
Guangzhou 35
Abidjan 32
Norwalk 32
Milan 27
Jiaxing 26
New York 26
Tianjin 26
Changsha 23
Dublin 23
Falls Church 23
Jinan 22
Falkenstein 19
Washington 19
Ogden 17
Shanghai 17
London 16
Kilburn 14
Nuremberg 13
Borås 12
Catania 12
Hefei 12
Kunming 11
Paris 10
Dallas 9
Frankfurt am Main 9
Redwood City 9
Vicenza 9
Zhengzhou 9
Aprilia 8
Portland 8
Fossò 7
Nürnberg 7
Turin 7
Vienna 7
Frederick 6
Hounslow 6
Indiana 6
Kharkiv 6
Rome 6
Sariyer 6
Tappahannock 6
Bologna 5
Haikou 5
Munich 5
Nagasaki 5
Taiyuan 5
Toronto 5
Treviso 5
West Lafayette 5
Belo Horizonte 4
Chicago 4
Hangzhou 4
Lisbon 4
Los Angeles 4
Messina 4
Middleboro 4
Parma 4
Rockville 4
Seongnam-si 4
Torri di Quartesolo 4
Baotou 3
Belém 3
Brussels 3
Central 3
Chiswick 3
Cutrofiano 3
Detroit 3
Dongguan 3
Fuzhou 3
Genoa 3
Ghent 3
Johannesburg 3
Las Vegas 3
Totale 13.914
Nome #
Personalized stem cell therapy to correct corneal defects due to a unique homozygous-heterozygous mosaicism of ectrodactyly-ectodermal dysplasia-clefting syndrome 212
Amiodarone and metabolite MDEA inhibit Ebola virus infection by interfering with the viral entry process 178
Novel variants of RPGR in X-linked retinitis pigmentosa families and genotype-phenotype correlation 168
Acyclovir resistance in herpes simplex virus type 1: biochemical and functional studies on the thymidine kinase of the highly resistant R100 strain 156
Relevance of DNA binding to the mechanism of anti-herpesvirus activity of benzhydrazone 148
Additive and antagonist effects of therapeutic gene combinations for suppression of HIV-1 infection 146
T cell engineering by a chimeric T cell receptor with antibody-type specificity for the HIV-1 gp120 143
Development of Lentiviral Vectors Simultaneously Expressing Multiple siRNAs Against CCR5, vif and tat/rev Genes for an HIV-1 Gene Therapy Approach 143
vOX2 glycoprotein of human herpesvirus 8 modulates human primary macrophages activity 142
Correction of Mutant p63 in EEC Syndrome Using siRNA Mediated Allele-Specific Silencing Restores Defective Stem Cell Function 140
Ebola Virus Entry: From Molecular Characterization to Drug Discovery 138
Analysis of human immunodeficiency virus type 1 vector cis- and trans-acting elements production by means of Semliki Forest Virus 137
Onopordum illyricum L., a Mediterranean plant, as a source of anti HIV-1 compounds 137
Onopordum illyricum L., a Mediterranean plant, as a source of anti HIV-1 compounds 135
Inhibition of ShcA isoforms p46/p52Shc enhances HIV-1 replication in CD4+ T-lymphocytes 130
6-aminoquinolones as new potential anti-HIV agents 129
Functional interaction between the ESCRT-I component TSG101 and the HSV-1 tegument ubiquitin specific protease 128
Antiviral activity of cationic amphiphilic drugs 126
null 125
Synthesis and biological activity of new quinolone derivatives 121
Effect of herpes simplex virus type 1 infection on nucleoside transport in HeLa S3 cells 121
A defective HIV-1 vector for gene transfer to human lymphocytes. 119
Mechanisms of HIV-1 Nucleocapsid Protein Inhibition by Lysyl-Peptidyl-Anthraquinone Conjugates 119
News and views from the 8th annual meeting of the Italian Society of Virology 118
Intracellular trafficking and maturation of herpes simplex virus type 1 gB and virus egress require functional biogenesis of multivesicular bodies 118
Lentiviral Vectors as Tools for the Study and Treatment of Glioblastoma 117
Alternate NF-κB-Independent Signaling Reactivation of Latent HIV-1 Provirus 117
Infection of a simian B cell line by human and simian immunodeficiency viruses 116
Transcriptionally targeted retroviral vector for combined suicide and immunomodulating gene therapy of thyroid cancer 116
SERPINB3 expression on B-cell surface in autoimmune diseases and hepatitis C virus-related chronic liver infection 116
HIV-1-mediated delivery of a short hairpin RNA targeting vascular endothelial growth factor in human retinal pigment epithelium cells 116
Design, synthesis and biological evaluation of TAR and cTAR binders as HIV-1 nucleocapsid inhibitors 115
Assessment of CMV load in solid organ transplant recipients by pp65 antigenemia and real-time quantitative DNA PCR assay: correlation with pp67 RNA detection. 115
Systemic efficacy of combined suicide/cytokine gene therapy in a murine model of hepatocellular carcinoma 114
Cellular uptake of phosphonylmethoxyalkylpurine derivatives 112
Activity of the matrix metalloproteinase-9 promoter in human normal and tumor cells 112
Perspectives on immunotherapy via oncolytic viruses 112
SERPINB3 expression on B-cell surface in autoimmune diseases and hepatitis C virus-related chronic liver infection 110
vOX2 glycoprotein of Human Herpesvirus 8 modulates human primary macrophages activity 109
Feline tetherin is characterized by a short N-terminal region and is counteracted by the feline immunodeficiency virus envelope glycoprotein 109
View and review on viral oncology research 108
Gene transfer of integration defective anti-HSV-1 meganuclease to human corneas ex vivo 108
Modulation of human macrophages gene expression by OX2 protein of HHV8 107
A novel de novo missense mutation in TP63 underlying germline mosaicism in AEC syndrome: implications for recurrence risk and prenatal diagnosis 107
Antiviral properties of quinolone-based drugs. 106
Herpes simplex virus type 1 can either suppress or enhance human immunodeficiency virus type 1 replication in CD4-positive T lymphocytes 106
New generation sequencing in pathogen discovery and microbial surveillance 106
Role of the feline immunodeficiency virus L-domain in the presence or absence of Gag processing: involvement of ubiquitin and Nedd4-2s ligase in viral egress 104
Increased expression of LGI1 gene triggers growth inhibition and apoptosis of neuroblastoma cells. 102
Nef and cell signaling transduction: a possible involvement in the pathogenesis of human immunodeficiency virus-associated dementia 102
The Persistent Infection of Tick Cells by Hazara orthonairovirus Is Mediated by Virus-Derived DNA Forms 102
The effect of the minor groove binding agent DAPI (4', 6-diamidino-2-phenyl-indole) on DNA-directed enzymes: an attempt to explain inhibition of plasmid expression in Escherichia coli 101
Hypericum hircinum L. components as new single-molecule inhibitors of both HIV-1 reverse transcriptase-associated DNA polymerase and ribonuclease H activities 101
Lentiviral-mediated RNAi in vivo silencing of Col6a1, a gene with complex tissue specific expression pattern 101
Antiviral treatment and virological monitoring of oseltamivir resistant influenza virus A(H1N1)pdm09 in a patient with chronic B lymphocytic leukemia 99
Antiviral treatment and virological monitoring of oseltamivir-resistant influenza virus A(H1N1)pdm09 in a patient with chronic B lymphocytic leukemia 99
Amiodarone increases positive-strand RNA virus replication in vitro: implications for its use in patients with viral infections 99
2-phenylquinolones as inhibitors of the HIV-1 Tat/TAR interaction. 98
Herpes simplex virus type 2 infection increases human immunodeficiency virus type 1 entry into human primary macrophages 96
CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5 95
Identification of novel X-linked gain-of-function RPGR-ORF15 mutation in Italian family with retinitis pigmentosa and pathologic myopia 95
Autochthonous hookworm-related cutaneous Larva migrans disease in Northeastern Italy: a case report 94
2-Phenylquinolones as inhibitors of the HIV-1 Tat-TAR interaction 94
Genetically modified immunocompetent cells in HIV infection 93
New anti-human immunodeficiency type 1 6-aminoquinolones: mechanism of action 93
TSG101 interacts with Herpes simplex virus 1 VP1/2 and is a substrate of VP1/2 ubiquitin-specific protease domain activity 93
Inhibition of human immunodeficiency virus type 1 tat-trans-activation-responsive region interaction by an antiviral quinolone derivative 92
From the traditional Chinese medicine plant Schisandra chinensis new scaffolds effective on HIV-1 reverse transcriptase resistant to non-nucleoside inhibitors 92
Survey of laboratory-acquired infections around the world in biosafety level 3 and 4 laboratories 90
The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry 90
SFV/HIV chimera as a new approach for HIV-1 antigen expression and delivery 89
CD4-INDEPENDENT INFECTION OF TWO CD4(-)/CCR5(-)/CXCR4(+) PRE-T-CELL LINES BY HUMAN AND SIMIAN IMMUNODEFICIENCY VIRUSES 89
Evaluation of biological effects of Kaposi's sarcoma-associated G protein-coupled receptor in THP-1 monocytic tumor cell line and in BJAB B-cell line 88
Summary of the 9th annual meeting of the Italian Society for Virology 88
Use of murine CXCR-4 as a second receptor by some T cell-tropic human immunodeficiency viruses 88
Analysis in human immunodeficiency virus type 1 vectors of cis-acting sequences that affect gene transfer into human lymphocytes 88
Small RNAs targeting the 5' end of the viral polymerase gene segments specifically interfere with influenza type A virus replication 87
Relevance of ionic effects on norfloxacin uptake by Escherichia coli 87
Production of influenza virus like particles by expression of engineered M1 proteins. 86
Analysis of Nef involvement in the development of HIV-1 Associated Dementia 85
HIV-1 Nef and cell signaling transduction: possible involvement in HIV-1 Associated Dementia (HAD) 85
Multi-target activity of Hemidesmus indicus decoction against innovative HIV-1 drug targets and characterization of Lupeol mode of action 85
Functional activity of KSHV vOX2 glycoprotein in macrophage: immunoactivator or immunosuppressor? 84
Formation of a unique cluster of G-quadruplex structures in the HIV-1 nef coding region: implications for antiviral activity 84
Coronaviruses: a paradigm of new emerging zoonotic diseases 84
Laser Scanning Confocal Microscopy: Application in Manufacturing and Research of Corneal Stem Cells 83
Anti-HIV gene therapy strategies combining multiple siRNA with the entry inhibitor 83
Immunotherapy: oral route to Holy Grail? 82
Cellular and transcriptional targeting of retroviral vectors for gene therapy of glioblastoma multiforme (GM). 82
Meeting report: Third Summer School on Innovative Approaches for Identification of Antiviral Agents (IAAASS) 82
Replication and neutralization of human immunodeficiency virus type 1 lacking the V1 and V2 variable loops of the gp120 envelope glycoprotein. 81
Dissecting the contribution of Gag domain in resistance development in HIV-1 patients failing ARV therapy 81
Progress with retroviral gene vectors 80
A model for the sequence-dependent DNA binding of 4',6-diamino-2-phenylindole (DAPI) 80
Combinatorial RNA interference as a gene therapy strategy for HIV-1 infection 79
Synthesis and biological evaluation of 2-phenylquinolones targeted at Tat/TAR recognition 79
Anti-HIV quinolones: screening of in vitro activity and recognition of viral nucleic acids targets 78
Aloe-emodin is a new type of anticancer agent with selective activity against neuroectodermal tumors 77
Comparative evaluation of three computerized algorithms for prediction of antiretroviral susceptibility from HIV type 1 genotype 77
Design, synthesis, and biological evaluation of 1,3-diarylpropenones as Dual Inhibitors of HIV-1 reverse transcriptase 77
Totale 10.654
Categoria #
all - tutte 66.467
article - articoli 43.769
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.102
Totale 111.338


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020970 0 0 0 0 0 0 0 0 291 361 165 153
2020/20212.243 71 173 61 143 100 298 67 200 374 217 320 219
2021/20222.554 73 417 293 130 82 113 133 223 125 32 290 643
2022/20232.423 493 252 67 250 388 355 18 148 282 31 115 24
2023/20241.219 35 185 187 119 101 114 89 44 29 57 142 117
2024/20252.613 20 372 182 147 703 129 233 384 443 0 0 0
Totale 18.031